Nina Blazeska

PHOTO: 2022 IEDB Virtual User Workshop - Day 1 to 3 (26 October to 28 October, 2022) - Presenters on Zoom Webinar Our team holds an annual user workshop in October/November to which we invite both...

Users will see in the IEDB receptor exports that there are two groups of fields for the VDJ Genes and for the CDR 1, 2, and 3 sequences; described as either 'curated' or 'calculated'. Below is the ...

IEDB tools users have the ability to predict against a series of alleles for both MHC Class I and Class II using the following tools: MHC-I Binding Predictions MHC-II Binding Predictions The two ...

  The data in the IEDB is primarily derived from scientific publications. These are designated as having the "Reference Type" of "Literature". This type of record has a PubMed identifier and an IED...

PHOTO: 2021 IEDB Virtual User Workshop - Day 1 (28 October 2021) - Presenters on Zoom Webinar Our team holds an annual user workshop in October/November to which we invite both those new to the IE...

The attached document is the agreed upon Statement of Work that the IEDB (contract number 75N93019C00001) has with the National Institute of Allergy and Infectious Diseases (NIAID). It outlines the...

The attachment on this page houses two key plans that were agreed upon with the National Institute of Allergy and Infectious Diseases (NIAID) at the outset of the Immune Epitope Database (IEDB) con...

IEDB Annual Compendium for 2020 This Compendium of the Immune Epitope Database and Analysis Resource, and consists of three sections. The first section contains a list of the antibody and T cell ep...

In 2020, the IEDB Expert Committee was established. It is a volunteer-based group of scientists with diverse backgrounds; from B and T cell expertise to immunotherapy and bioinformatic tools experi...

The following categories are assigned during data curation based on what the authors indicate in the paper: Positive High Positive Intermediate Positive Low If there is no binding or outcome in t...